Pharmaceuticals

Goldman Sachs’s Buyout Arm Agrees $2B Deal for Norgine

The purchase values Amsterdam-based Norgine at about 1.8 billion euros ($1.9 billion).

May 26, 2022

The acquisition will complement Alcon’s portfolio in the large and fast-growing dry eye category.

May 23, 2022

Grupo Somar offers a range of products and has R&D and manufacturing expertise, with six production facilities.

May 18, 2022

NQPE invests in tech-enabled pharmaceutical firms that improve medical outcomes and reduce costs.

May 12, 2022

The consortium becomes the leading shareholder in Lotus Pharmaceuticals, and owner of Alvogen Malta Holding

May 11, 2022

Pfizer will pay $148.50 a share for all of New Haven, Connecticut-based Biohaven’s outstanding stock.

May 10, 2022

The partnership will accelerate PANTHERx Rare's growth as a pharmacy care delivery model for patients with rare diseases.

May 06, 2022

Under the terms of the deal, CordenPharma’s founders will reinvest as partners with Astorg.

May 03, 2022